CURATIVE BIOSCIENCES, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0015 USD | -.--% |
|
-.--% | -.--% |
Financials (USD)
| Sales 2016 | - | Sales 2017 | - | Capitalization | 1.77M |
|---|---|---|---|---|---|
| Net income 2016 | -1M | Net income 2017 | - | EV / Sales 2016 | - |
| Net Debt 2016 | 50.03K | Net Debt 2017 | 62.83K | EV / Sales 2017 | - |
| P/E ratio 2016 |
-3.53
x | P/E ratio 2017 |
-33.2
x | Employees | - |
| Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 70.57% |
More Fundamentals
* Assessed data
Curative Biosciences, Inc., formerly Amaize Beverage Corporation, is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD (hemp derived Cannabidiol). The Companyâs product segment is focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The Company through its consumer products business manufactures market and sells consumer products containing plant-based CBD under the brand Curative Biosciences.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +40.83% | 4.64B | |
| +141.02% | 2.69B | |
| +109.52% | 80.19M | |
| +161.54% | 51.55M |
- Stock Market
- Equities
- CBDX Stock
- CBDX Stock
